Skip to Content

Grapefruit USA Inc GPFT

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Grapefruit USA Inc is a Delaware corporation that is a fully audited and licensed cannabis manufacturer and distributor in the legal cannabis marketplace with its own patented and branded line of products. The company manufactures and distributes products to licensed cannabis product businesses. Grapefruit has harnessed cutting-edge science and technology to bring patented, truly disruptive products to the medicinal and recreational cannabis marketplace, fundamentally changing the way individuals use THC, CBDs, and hemp-derived CBDs and capitalizing on the rise in demand for these products. It owns and operates a California-licensed cannabis extraction laboratory and wholesale distribution facility in the Coachillin' Canna-Business Park near Palm Springs, California.

10866 Wilshire Boulevard, Suite 225
Los Angeles, CA, 90024
T +1 310 575-1175
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 14